C2DBench / README.md
HZPM's picture
add gated-access terms and contact fields
11a09f0 verified
|
Raw History Blame Contribute Delete
5.94 kB
---
license: cc-by-4.0
extra_gated_heading: Access C2DBench
extra_gated_prompt: >-
C2DBench is derived from public sources (Norman et al. 2019, GEO GSE133344, via
scPerturb; DGIdb 5.0). It contains no raw sequencing data and no human-subject data —
K562 is an immortalised cell line. Please confirm the following before access.
extra_gated_fields:
Full name: text
Email: text
Affiliation: text
Intended use: text
I will cite Norman et al 2019 and DGIdb alongside this dataset: checkbox
I understand drug_reference lists are computational nominations, not evidence of efficacy, and will not be used to inform clinical or treatment decisions: checkbox
extra_gated_button_content: Request access
task_categories: [feature-extraction, question-answering]
tags: [single-cell, perturb-seq, crispra, drug-discovery, agents, biology]
configs:
- config_name: default
data_files:
- split: eval
path: data/eval.parquet
- split: reference_library
path: data/reference_library.parquet
---
# C2DBench — Cell Shift to Drug (Norman v1)
Given two cell populations — untouched controls and cells where genes were switched on
— infer **what was changed**, **what else is functionally involved**, and **what drugs
might act on it**.
Built from Norman et al. 2019, CRISPR activation in K562. Self-contained: no external
files needed.
## Task
| Stage | Target | Graded |
|---|---|---|
| **List 1** | the activated gene(s) | ✅ `list1_gold` |
| **List 2** | functionally related genes | ✅ `list2_gold` |
| **Drug list** | compounds acting on those pathways | ⚠️ `drug_reference` provided; no efficacy key |
## Splits
**There is no train/val/test. This is an agentic evaluation set — every row is scored.**
The perception model (soft-prompt adapter over cell embeddings) is trained elsewhere;
nothing here is training data.
| Split | Rows | |
|---|---|---|
| `eval` | 690 | every task item |
| `reference_library` | 105 | one profile per single-gene condition — the agent may consult this |
Within `eval`, stratify on `n_target_genes`:
| `n_target_genes` | Rows | Difficulty |
|---|---|---|
| 2 | 340 | **the real test** — the pair's combined profile was never observed, only its two constituents, so it must be composed |
| 1 | 310 | near-lookup — the gene's own profile sits in `reference_library` |
| 0 | 40 | sham (control-vs-control), empty `list1_gold` — naming genes here is a hallucination |
Every row is the same full trace: `cell pair → list 1 → list 2 → drug list`.
The difficulty gap is the point. Nearest-centroid solves single-gene items at 0.905;
the best trivial method on two-gene items reaches 0.335. Report the two strata
separately — a headline number pooled across them mostly measures the easy half.
`reference_library` is study material, not leakage: composing those profiles into an
unseen pair *is* the task.
## Columns
| Column | |
|---|---|
| `control_profile`, `perturbed_profile`, `delta` | 1,983-dim log1p CP10K pseudobulk |
| `top_up_genes`, `top_down_genes` | top 25 movers with logFC (JSON) — for text/LLM arms |
| `list1_gold`, `list2_gold` | answer keys |
| `drug_reference` | specificity-ranked drug nominations (JSON, median 20) |
| `drug_gold` | `null` — Norman has no drug treatments |
| `n_target_genes` | 2 = real test, 1 = near-lookup, 0 = sham |
| `effect_tier`, `snr` | strong / moderate / weak / marginal |
| `qc_energy_distance`, `qc_permutation_p` | per-item separation statistics |
| `leakage_control_target_logfc` | held-out target genes — **do not add to features** |
| `control_cell_idx`, `perturbed_cell_idx` | row offsets into the source h5ad |
## Baselines (two-gene items, n=340)
| Method | top-1 | top-5 | top-20 |
|---|---|---|---|
| **Additive composition** — the bar | **0.335** | 0.603 | 0.732 |
| Chance (5,460 candidate pairs) | 0.00018 | — | — |
`run_baseline.py` reproduces this from the parquet files alone.
## Three things to know
**Targets are masked.** CRISPRa raises the activated gene's own transcript, so reading
the top mover recovers a true gene 89.6% of the time. All 102 target genes are removed
from every visible field; that baseline then scores 0.000. Unmasked values are kept in
`leakage_control_target_logfc` for measuring the leak, not for features.
**List 2 is measured, not looked up.** Two genes are related if activating them
produces similar shifts (top-10, cross-half reproducibility 0.847). A GO/Reactome key
would be circular — solvers can query those databases. This one recovers known families
9× above chance.
**Pairs are lane- and depth-matched.** Perturbed cells run ~18% shallower than controls,
and some encoders read depth almost perfectly, so unmatched a model can detect
"perturbed" from read depth alone. After matching, 98.5% of real pairs separate at
p<0.05 with a 0% sham false-positive rate.
## Limits
One cell line, one lab, CRISPR activation only. 340 two-gene items ranks methods but won't
resolve small differences. Scoring drug *efficacy* needs measured drug responses
(sciPlex, LINCS, Tahoe) — not available in Norman.
## Sources
Derived data only; no raw sequencing redistributed.
- **Norman TM et al.** *Exploring genetic interaction manifolds constructed from rich
single-cell phenotypes.* Science 365:786–793 (2019).
[10.1126/science.aax4438](https://doi.org/10.1126/science.aax4438) · GEO **GSE133344**
- **Peidli S et al.** *scPerturb: harmonized single-cell perturbation data.*
Nature Methods (2024) — source of the processed object.
- **DGIdb 5.0**, Nucleic Acids Research (2024) — `drug_reference`, queried once and
frozen. DGIdb aggregates upstream sources with varying licences; see
[dgidb.org](https://dgidb.org) before redistributing that column.
K562 is an immortalised cell line, not human-subject material. No embeddings included.
Please cite Norman et al. and DGIdb alongside this dataset.